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THE use of sleeping tablets has recently been the subject of much discussion and
controversy. Criticism of their use has been based on doubts about their value and
their adverse reactions.
THE VALUE OF HYPNOTICS
The value of all medication for sleep has been called into question. Although
current research is adding to our knowledge of what happens to the brain, the
circulation and the endocrine system during sleep, we are ignorant of how much
sleep is needed and what processes need to go on during sleep. There is evidence
(Oswald 1973) that hypnotics interfere with the physiological features of normal
sleep and that their effects on the performance of skilled tasks persist during the
following day and possibly for several days. It has been shown that some patients
who take a hypnotic at night are abnormally restless in the early hours of the fol-
lowing morning and that nocturnal restlessness is common for many nights after
stopping sleeping tablets after more than a few days of regular use. This restless-
ness may convince patients, and doctors, that medication should be restarted and
is a major factor in perpetuating the use of hypnotics.
THE ADVERSE REACTIONS OF HYPNOTICS
Barbiturates which were the choice in 80 per cent of prescriptions written for
hypnotics fifteen years ago, have been the subject of critical comment in recent
years (B.M.J. Leading Article, 1975: Wells, 1975). They may lead to dependence
and they can cause serious withdrawal symptoms. They have in some parts of the
United Kingdom become drugs of abuse, popular with teenagers and those who
wish to potentiate the effects of alcohol. They have become commonly used drugs
for self poisoning either to draw attention to distress or to commit suicide. Be-
cause of the evidence of their misuse the Campaign for the Use and Restriction
of Barbiturates (C.U.R.B.) was launched in 1975 to reduce the prescribing and
availability of barbiturates. Barbiturates have also been criticised, although other
hypnotics are probably just as bad, because in elderly patients with reduced cereb-
ral reserves, they often cause confusion at night and uns'eadiness and drowsiness
the following day. They are potent inducers of hepatic enzymes and interfere with
the metabolism of many drugs, especially the anticoagulants.
166It has been widely recommended that other hypno.ics should be substituted for
the barbiturates. Of those currently available the benzodiazepines seem the best:
they do not induce hepatic enzymes, are not so liable to cause serious dependence
and are seldom dangerous in overdose. However, even nitrazepam (Mogadon) has
not been in use long enough to assess its disadvantages when widely used in a
community. Chloral and its derivatives (Noctec, Tricloryl, Welldorm) all induce
hepatic enzymes and are gastric irritants causing dyspepsia. Methaqualone, either
alone (Melsedin, Revonal) or in combination with diphenhydramine (Mandrax)
also induces hepatic enzymes. Moreover, Mandrax has been widely misused, and
overdose, especially if combined with alcohol, is danigerous and often difficult to
trea'. Glutethimide (Doriden) another enzyme inducer, occasionally causes neuro-
pathy. All the evidence suggests that all hypnotics, not only the barbiturates,
should be used with greater caution.
THE PRESCRIBING OF HYPNOTICS IN NORTHERN IRELAND
The prescribing of hypnotics in Northern Ireland has been under surveillance
since 1966. The drugs that are prescribed are lis'ed in Table 1 with their "agreed
TABLE 1
Agreed daily doses for sleeping tablets
Approved name Commonly used
proprietary names Agreed daily doses
1. BARBITURATE
a) Amylobarbitone Amytal 100 mg.
Mylomide
b) Butobarbitone Soneryl 100 mg.
c) Cyclobarbitone Rapidal 200 mg.
Phanodorm
d) Heptabarbitone Medomin 200 mg.
e) Methylphenobarbitone Prominal 100 mg.
f) Pentobarbitone Nembutal 100 mg.
g) Quinalbarbitone Seconal 100 mg.
2. BARBITURATE MIXTURES
a) Amylobarbitone and
Quinalbarbitone Tuinal 200 mg. tablet
b) Quinalbarbitone I
Butobarbitone Ethobral 1 tablet
Phenobarbitone
3. NoN-BARBITURATES
a) Chloral Noctec 1.0 g.
Somnos
b) Dichloralphenazone Welldorm 1.3 g.
Paedo-sed
c) Triclofos Tricloryl 1.0 g.
d) Glutethimide Doriden 250 mg.
e) Methaqualone Melsed 150 mg.
Quaalude 150 mg.
(+ diphenhydramine) Mandrax 1 tablet
f) Nitrazepam Mogadon 5 mg.
167daily doses". Details of the methods used in the survey and the basis on which
daily doses of drugs are agreed are given in the first paper of this series (Elmes,
Hood and Wade, 1976).
Hypnotics were prescribed at a rate of 30 daily doses/1,000 persons on doctors
lists/day in 1966 (Fig. 1). This rate rose sharply between 1966 and 1969 to 42.7
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FIG. 1. The rise in total prescribing was most rapid between 1966 and 1969 and has slowed
down since then. The changes in ithe two most commonly prescribed non-barbiturate sleeping
tablets introduced in the early 1960s are also shown.
daily doses/1,000/day. Since that time it has remained fairly constant and in the
second quarter of 1974, doctors prescribed on the average 44.3 daily doses of
168hypnotics per 1,000 persons/day. Unfortunately, it is not possible to relate the
prescribing of these drugs to the age of patients, but assuming that hypnotics are
seldom prescribed for children under 15 the data suggest that during the late
1960's and early 1970's about one in every 15 adults was being prescribed sleeping
tablets. The prescribing was above the average for the province in Belfast (59
FIG. 2
Prescribing of Sleeping Tablets in General Practice
Second Quarter 1973
(Daily Doses/l,000 Population/Day)
> 1 standard deviation above the mean
O Mean (43.7) ± 1 standard deviation (9.0)
O >1 standard deviation below the mean
FIG. 2- The highest prescribing (59.1Idaily doses!1,OOO day) is in Belfast and neighbouring
Co. Down and the lowest is in Co. Londonderry.
169daily doses/1,000/day) and County Down (56 daily doses/1,000/day) and below
the average in County Londonderry (34 daily doses/1,000/day) and the City of
Londonderry (31 daily doses/1,000/day) (Fig. 2).
Although the use of hypnotics has increased since 1966, the geographical dis-
tribution of high and low prescribing has remained constant and the prescribing
of hypnotics has not been rela'ed either temporarily or geographically to the level
of civil strife which broke out in 1969 and has persisted sporadically in some areas
of Northern Ireland ever since. In 1973 a reorganisation of the health services
took place and data on the prescribing of hypnotics in 1974 is available for the
new Health Services Districts. The variations in prescribing be:ween these 17
districts (Table 2) are greater than was found between the previous counties and
TABLE 2
Prescribing of Hypnotics in Northern Ireland
by Health Services Districts - 1974
Area Daily doses/i000/day
East Belfast 52.7




North Down and Ards 57.7
Ballymena and Antrim 27.3
Coleraine, Ballymoney and Moyle 29.4
Larne and Carrickfergus 32.0
Magherafelt and Cookstown 28.4
Newtownabbey 26.8
Craigavon and Banbridge 36.7
Dungannon and Armagh 32.2
Newry and Mourne 41.4
Fermanagh 23.5
Londonderry, Limavady and Strabane 24.7
Omagh 34.7
Northern Ireland Average 40.4
county boroughs (Fig. 2). The highest prescribing of hypnotics in 1974 was in
South Belfast, 76.6 daily doses/1,000/day and the adjacent part of County Down
(Bangor, Holywood and Newtownards District) 57.7 daily doses/1,000/day. The
lowest was in Fermanagh 23.5 daily doses/1,000/day, but the Londonderry, Lima-
vady, Strabane District and the Newtownabbey District were almost as low.
170THE HYPNOTICS PRESCRIBED
The rate of prescribing of barbiturates was 24 daily doses/1,000/day in 1966
and it represented more than 80 per cent of hypnotic prescribing (Fig. 1). Despite
the greater increase in the prescribing of hypnotics since 1966, the prescribing of
barbiturates has decreased to 20 daily doses/1,000/day in 1974 and it now consti-
tutes only 45 per cent of all hypnotic prescribing.
The increase in the prescribing of hypnotics between 1966 and 1969 coincided
with the introduction and vigorous promotion of two new proprietary prepara-
tions, Mandrax and Mogadon (Fig. 1). At first Mandrax was the most popular of
these two preparations, but reports of its misuse in combination with alcohol by
young people led to a reduction in prescribing after 1969. By 1974 the rate was
only 2 daily doses/1,000/day. It is not known whether the prescriptions written
for Mandrax in 1974 are for a residue of patients originally given the drug in the
1960's when it was popular, or whether it is still being prescribed for the first time
for some patients by doctors who consider the effectiveness of this preparation
outweighs its disadvantages.
Mogadon was used less than Mandrax at first but the rate of prescribing of this
drug has increased and is still increasing so that in 1974, it equalled that of all the
barbiturates, 20 daily doses/1,000/day. This increased prescribing of Mogadon
has probably been partly due to the adverse publicity given first to Mandrax and
now to the barbiturates.
Although the prescribing of hypnotics varies very greatly from county to
county (Fig. 2), the increase in the use of Mogadon and the decrease in the use of
barbiturates has occurred in all areas, both where the prescribing of hypnotics
was high as in Belfast or low as in Londonderry.
DIFFERENCES BETWEEN DOCTORS
The average figures for prescribing in counties or administrative districts con-
ceal the great variations that exist in the prescribing habits of individual doctors.
These differences are demonstrated in a survey of the prescribing habits of five
selected groups of doctors in 1972, 1973 and 1974. Their prescribing has been
compared with the average prescribing for the whole province during those years
(Table 3).
Group I was a control group of doctors in 19 practices chosen because their total
use of hypnotics in 1972 was the same as the average of the whole province.
Seven of the practices were in Belfast, three in Co. Down, two in Co. Armagh,
three in Co. Antrim and two in Co. Londonderry. The pattern of prescribing of
this group was similar to the average of the whole province except that they were
rather higher prescribers of Mandrax. Over the 3 years the proportion of their
prescriptions written for barbiturates and Mandrax fell from 44 per cent and 19
per cent respectively to 39 per cent and 7 per cent. The proportion of prescriptions
for Mogadon rose from 35 per cent to 48 per cent so becoming similar to the
provincial average.
171TABLE 3
Prescribing of Groups of Doctors
Group No. Description Year Average
(see text) prescribing of PERCENT OF HYPNOTIC
hypnotics PRESCRIBING
Daily doses/
1000/day Barbiturates Mandrax Mogadon
I CONTROL 1972 40.7 44 19 35
1973 40.8 41 12 41
1974 40.3 39 7 48
II HIGH 1972 85.2 56 10 28
HYPNOTIC 1973 85.0 54 6 38
PRESCRIBERS 1974 83.5 49 4 46
III OVER 75 % 1972 43.5 83 5 11
BARBITURATES 1973 43.0 76 3 18
1974 43.4 68 1 29
IV OVER 65% 1972 22.9 17 5 75
MOGADON 1973 23.5 21 3 74
1974 25.7 17 3 78
V OVER 35% 1972 35.5 31 45 18
MANDRAX 1973 36.7 27 36 29
1974 36.8 31 23 41
PROVINCE AVERAGE 1972 40.7 51 12 34
1973 41.0 48 8 42
1974 40.4 43 5 49
Group II was a group of 13 doctors who were high prescribers of hypnotic drugs
and who all prescribed more than 85 daily doses/1,000/day of these drugs in 1972.
The high prescribing of hypnotics by these doctors persisted throughout the three
years of the survey. They prescribed a slightly higher proportion of barbiturates
and a smaller proportion of Mandrax and Mogadon than was prescribed by the
average doctor. Over the 3-year period, the propor.ion of barbiturates fell from
56 per cent to 49 per cent in line with the trend apparent in the whole province
and prescribing of Mogadon rose to 46 per cent of all hypnotics.
Group 111 was a group of doctors from 21 practices, scat ered across the province,
chosen because in 1972 more than 75 per cent of their prescriptions for hypnotics
were for barbiturates. The overall use of hypnotics by these doctors was not
unduly high, 43 daily doses/1,000/day, and they were infrequent prescribers of
Mandrax. Over the 3-year period there was a sharp fall in the proportion of their
prescriptions written for barbiturates from 83 per cent to 68 per cent and this
was accompanied by an increase in the proportion of prescriptions for Mogadon
from 11 to 29 per cent.
Group IV was a group of doctors in 19 practices chosen because in 1972 more
than 65 per cent of their prescriptions for hypnotics were for Mogadon. These
doctors were low users of hypnotics 23 daily doses/1,000/day and they showed less
change in their prescribing than any other Group over the 3-year period.
172Group V There were in 1972 none of the very heavy users of Mandrax that
there had been in 1969 but a group of doclors from 14 practices was chosen be-
cause in 1972 more than 35 per cent of their prescriptions were for Mandrax.
These doctors were below the average of the province in their prescribing of
hypnotics, 35.5 daily doses/1,000/day. They differed from other groups because
they replaced their prescribing of Mandrax over the 3-year period by Mogadon
but did not reduce their barbiturate prescribing.
This small survey not only illustrates the great differences which may exist be-
tween doctors but it shows how remarkably constant the overall prescribing of
sleeping tablets by doc ors is. The survey suggests that a decrease in the use of
barbiturates and Mandrax has occurred, the fall being greatest amongst those
who were initially the highest users. There has been a rise in the prescribing of
Mogadon, the biggest rise being amongst those who were ini ially the lowest
prescribers of the drug.
PRESCRIBING AND THE DATE OF GRADUATION OF DOCTORS
The age of prescribing doctors was not available but the date of graduation was
known. Four graduation periods were selected (Table 4). The two groups who
graduated before 1947 were taught in medical school at a time when only chloral-
hydrate or the barbiturates were available. Those graduating before 1957 would
have learnt as students about non-barbiturate hypnotics such as thalidomide and
TABLE 4
Prescribing and Date of Graduation
1972 1973 1974
Graduation Date (1) (2) (1) (2) (1) (2)
Pre 1935 34.3 48 36.1 47 34.9 40
1944 - 47 36.7 49 38.7 46 39.4 41
1953 - 57 35.2 50 35.3 47 38.2 45
1961 - 68 41.7 48 39.7 45 39.3 42
Provincial Average 51 48 43
Column (1) gives the prescribing of hypnotics as daily doses/1000/day
Column (2) gives percentage barbiturates prescribed
glute4himide, and only those graduating in the last period 1961-68 would have
heard about Mogadon and Mandrax during undergraduate or early postgraduate
days. There was no significant difference between the four groups either in respect
of their total prescribing of sleeping drugs or their prescribing of barbiturates.
During the three-year period all showed the expected fall in their use of barbitu-
rates. Doctors graduating before 1935 showed the lowest overall prescribing of
hypnotics and the lowest proportionate use of barbiturates.
173PRESCRIBING AND PRACTICE SIZE
There were 26 practices with less than 1,000 patien's per doctor and 35 prac-
tices with over 3,000 patients per doctor. These two groups of practices were com-
pared with 97 practices with between 1,900 and 2,300 patients per doctor. The
mean size of practice in Nor.hern Ireland is 2,125 patients per doctor.
It was found that the large practices and those with 1,900-2,300 patients/
doctor prescribed 39.5 and 37.7 daily doses!1,000/day of hypnotic drugs respec-
tively which was not significantly different from the province as a whole. In the
26 small practices the prescribing was twice as high, 78.3 daily doses!1,000/day
(P<0.05 using the paired T test).
INTERNATIONAL COMPARISONS
The prescribing of hypnotics in Northern Ireland has been compared with the
prescribing of these drugs in Norway where the data is derived from information
about the supply of drugs on prescription by pharmacists of the state drug
monopoly, Norsk Medicinaldepo+, to the community. For this comparison, phen-
obarbitone is added to the Northern Ireland figures because it is used in Norway
FIG. 3
Comparisons between Northern Ireland and Norway
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FIG. 3. In the Norwegian data, phenobarbitone is included as it has a significant use as a
hypnotic. For the sake of an exact comparison phenobarbitone has been included in the con-
struction of the Northern Ireland graph for Fig. 3, but because it is not used significantly as
a hypnotic in Northern Ireland, it is excluded from Fig. 1 and Fig. 2 and from the tables.
Other slight discrepancies between the graphs and the tables are due to the exclusion of rarely
prescribed hypnotic mixtures from the comparisons between doctors and geographical areas.
174as a hypnotic and is included in the Norwegian hypnotic prescribing. In both
countries, there has been a rise in the prescribing of hypnotics since 1966 to 48
daily doses/1,000/day in Northern Ireland and 42 daily doses/1,000/day in Nor-
way. Figure 3 shows that in Norway, the use of barbitura'es was already declin-
ing in 1967. In 1974, non-barbiturates represented 78 per cent of all the hypnotics
prescribed in Norway. In Norway there has been no serious misuse of Mandrax
as was encountered in Belfast in the late 1960's and about 14 per cent of the pre-
scribing is still Mandrax and only 31 per cent of it is Mogadon.
Detailed information about the doses of hypnotics prescribed by individual
doctors or practices in relation to the number of people in the community is not
yet available from England. However, the number of prescriptions written per
1,000 of the population can be estimated and in Fig. 4 is compared with similar
data from Northern Ireland. The prescribing of all hypnotics and of the barbitu-
rates was higher in England than in Northern Ireland in 1966. It has fallen
steadily since that time and in 1973, the number of prescriptions per 1,000 per-
sons/day, was similar in the two countries for all hypnotics, for barbiturate hyp-
notics and for non-barbiturate hypnotics.
FIG. 4
Comparisons between Northern Ireland and England by
Number of Prescriptions
NORTHERN I RELAND ENGLAND
TOTAL









1966 68 70 72 74 1965 67 69 71 73
FIa 4. Although in 1966 prescribing of sleeping tablets in London seemed to be higher than
in Northern Ireland, the 1gradual fall which has occurred since has made the English prescrib-
ing both in total and In distribution between barbiturates and non-barbiturates approximnately
the same.
175DISCUSSION AND CONCLUSIONS
The prescribing of hypnotics in Northern Ireland has risen during the last
eight years but may now be levelling off between 40 and 45 daily doses/1,000/day.
In 1974, the average rate of prescribing of hypnotics in the province was about
44 daily doses/1,000/day. This rate varied greatly from area to area. It was three
times higher in South Belfast, 76.6 daily doses/1,000/day than in Fermanagh,
23.5 daily doses/1,000/day. The rate of prescribing of hypnotics in Northern
Ireland does not appear to have been affec:ed by the recent civil strife and it was
not, in 1974, dissimilar from that of Norway or England.
Although there are great variations from practitioner to practitioner in their
prescribing of hypnotics, an individual practitioner seems to persist in his pre-
scribing habits, the high prescriber remaining a high prescriber and the low re-
maining a low prescriber even though their choice of hypnotic drugs changes.
Indeed, there has been a decrease in the use of barbiturates and a marked
increase in the prescribing of nitrazepam (Mogadon) a benzodiazepine and this
change is apparent in the prescribing of all doc ors whether high or low pre-
scribers of hypnotics. Mandrax and other non-barbiturate hypnotics apart from
Mogadon have become less popular in the last few years.
It is not difficult to understand why there is such great variation in the pre-
scribing of sleeping tablets. The complaint of sleeplessness is subjective and a
doctor in deciding whether to prescribe for it or not relies partly on knowledge
of the patient's character and partly on the vehemence of his complaints: there
are no objective criteria on which he can rely. Indeed, the few studies which have
been carried out, usually in hospitals or under laboratory conditions show that
there is a very poor correlation between the complaints a patient makes of sleep-
lessness and the number of hours of sleep which are actually recorded. It is known
too that the placebo effects of an impressive looking tablet or capsule may be
considerable in the treatment of these complaints.
The findings of this survey suggest that the prescribing of sleeping tablets is not
determined predominantly by the medical needs of patients. It is more likely that
sleeping tablets are prescribed by dociors mainly in response to demands from
patients and that these vary from area to area according to the social climate, the
sophistication of the community, its concepts of what constitutes illness and its
attitudes to drugs and drug taking. The doctor may be influenced by his training
in medical school, his postgraduate experience and drug advertising but he too is
probably greatly influenced by the attitudes to the use of drugs prevalent in his
community. There is some evidence that doctors with small numbers of patients
are more likely than others to accede to the demands of their patients.
If a rational policy for prescribing hypnotics is to be developed it is necessary
to find out more than is at present known about patients who demand sleeping
tablets, why they need them and what benefits or harm they derive from taking
them. Yet even now the evidence already suggests that the long term effects of
any hypnotic on sleep and cerebral activity are such that they should not be pre-
176scribed to any patient unless there is a very good reason and in any case for only
a short period of time.
SUMMARY
The prescribing of sleeping tablets and medicines by Northern Ireland general
practitioners has been analysed for the years 1966-1974. Total prescribing has
risen from 30 daily doses per 1,000 of population per day to 44 daily doses, most
of the increase occurring between 1966 and 1969. A combination of methaqua-
lone and diphenhydramine was popular for several years until teenage abuse led
doctors to reduce their prescribing. Prescribing of hypnotics is highest in a subur-
ban area of Belfast and lowest in remo'e country areas, it bears no relationship
to civil strife or to the age of the prescribing doctor. Doctors with small practices
prescribe twice as much per 1,000 of their patients as doctors with average or
large practices. All doctors have tended to replace barbiturates (which amounted
to 80 per cent of hypnotic prescribing in 1966) by nitrazepam which now equals
in volume the prescribing of all the barbiturate hypnotics added together. Com-
parisons are made with prescribing patterns in England and in Norway.
REFERENCES
British Medical Journal (1975). Leading Article. Barbituthte on the way out. British Medical
Journal, 3, 725.
ELMES, P. C., HOOD, H. and WADE, 0. L. (1976). Prescribing in Northern Ireland: Methods
of Analysis. Ulster Medical Journal, 45, 56.
OSWALD, I. (1973). Sleep. Physiology and Pharmacology. Prescribers' Journal, 13, No. 5,
100-104.
WELLS, F. 0. (1975). Are our barbiturates really necessary? British Medical Journal, 3, 285.
177